Tetrazole is a five-membered ring structure composed of four nitrogen atoms and one carbon atom and is used as an intermediate in the synthesis of pharmaceuticals, especially cephalosporins. Tetrazole and its derivatives have been reported to possess anti--nociceptive (1), anti-inflammatory (2), antimicrobial (3) and anticonvulsant properties (4, 5 
of tetramethylsilane. Mass spectra were recorded on a mass spectrometer (Jeol JMS-DX 303 (Jeol, Japan) and Finnigan MAT 8230 (Finnigan MAT, Germany). Elemental analyses were performed on a Heraeus Carlo Erba 1108 (Elementar, USA) and the analyses were within ± 0.4 % of theoretical values. [1, 2, 3] triazol-1-yl)propanonitrile (1) Benzotriazole (50 mmol) was mixed with acrylonitrile (12.5 mL) and cooled in an ice bath. A resorcinol crystal was added to prevent polymerization. Triton B (2 mL, 40 % V/V) was added dropwise under shaking and a vigorous reaction was observed. It was allowed to subside and was then refluxed on a steam bath for 2 h. The solution was cooled, extracted with ethylene dichloride and dried over anhydrous sodium sulphate. 
Synthesis of 3-(1H-Benzo[d]

Synthesis of 1-[2-(1H-tetrazol-5-yl)-ethyl]-1H-benzotriazole (2)
Equimolar quantities of compound (1), sodium azide, dimethylformamide (10 mL) and ammonium chloride were heated in an oil bath for 7 h at 125°C. The solvent was removed under reduced pressure, the residue was dissolved in 100 mL of water and carefully acidified with concentrated hydrochloric acid to pH 2. The solution was cooled to 5°C in an ice bath. Compound 2 was recrystallized from aqueous methanol.
Synthesis of 1-[2-(1H-tetrazol-5-yl)ethyl]-1H-benzo[d][1,2,3]triazoles (3a-h). General procedure
Compound 2 was treated with an equimolar amount of aromatic acid chlorides in 10 mL of sodium bicarbonate solution (10 % m/V). The mixture was shaken vigorously until the odor of aromatic acid chloride disappeared. The solids which separated out were filtered and dried. Recrystallization of the dried compounds from aqueous ethanol yielded compounds 3a-h. 
Pharmacological screening
Acute toxicity study. -This involves estimation of the median lethal dose (LD 50 ) (12), which is the dose that will kill 50 % of the animal population within 24 h post treatment with the test substance. All animal experiments were conducted under the conditions of the Animal Scientific Procedures. The experimental protocol was approved by the Animal Care Review Committee of the AK College of Pharmacy, India. Groups of Swiss albino mice consisted of six animals and were maintained in colony cages at 25 ± 2°C, relative humidity of 45-55 %, under a 12 h light and dark cycle; they were fed standard animal feed and water ad libitum. They were treated intraperitoneally with different doses of test compounds (200, 400, 600, 800, 1000 mg kg -1 ). The animals were then observed for 24 h for any behavioral effects such as nervousness, excitement, dullness, in-coordination or even death. The LD 50 was found to be 180 mg kg -1 .
Hot plate method. -All the newly synthesized compounds were tested for anti-nociceptive activity by the Eddy and Leimbach method (13). Swiss albino mice were divided into ten groups of six mice each. One group served as control and was administered 0.5 % (V/V) Tween 80 (0.5 mL) suspension. One group was administered the standard drug pentazocine (Sigma, USA) intraperitoneally at a dose of 5 mg kg -1 15 minutes before the analgesic activity evaluation. Tween 80 suspension (0.5 %, V/V) of test compounds 3a-h was administered intraperitoneally at a dose at 18 mg kg -1 to the remaining groups 15 minutes before the analgesic activity evaluation. The reaction time in seconds was noted for all the groups on Eddy's hot plates before and 15 minutes after administration of test compounds and pentazocine (Table III) . Control -no synthesized compound and paracetamol. a Mean ± SEM (n = 6). Significant difference compared with the control: b p < 0.001, c p < 0.01.
Acetic acid induced writhing method. -
The synthesized compounds were also tested for anti-nociceptive activity by the acetic acid induced writhing method (14). The animals were divided into ten groups of six. The control group of animals was administered 0.5 % (V/V) Tween 80 (0.5 mL) suspension. The standard drug paracetamol (Micro Labs, India) was administered intraperitoneally at a dose of 2.5 mg kg -1 . Tween 80 suspension (0.5 %, V/V) of test compounds were administered intraperitoneally at a dose of 18 mg kg -1 . Twenty minutes after administration of the test compounds and a standard, all groups of mice were given the writhing agent, 3 % (V/V) aqueous acetic acid at a dose of 2 mL kg -1 intraperitoneally. The total number of writhings produced in these animals was counted visually for 15 minutes and the number of writhings produced in treated groups was compared with that in the control group. The results given in Table  IV are expressed as percentage protection.
Anti-inflammatory activity. -The anti-inflammatory activity was evaluated by the carragenean induced paw edema method (15). Albino rats of Wistar strain, weighing 100-200 g, of either sex were divided into ten groups of six animals each. The animals were maintained under normal environmental conditions. They were fed standard feed and water ad libitum. Tween 80 suspension (0.5 %, V/V) of test compounds was administered intraperitoneally at a dose of 18 mg kg -1 . The control group was given only 0.5 % (V/V) Tween 80 (0.5 mL) suspension. One group was administered diclofenac sodium as standard, intraperitoneally at a dose of 2 mg kg -1 . Thirty minutes after the administration of test compounds and diclofenac sodium, paw edema was induced in albino rats by injecting 0.1 mL of carragenean suspension (1 %, V/V in normal saline), into subplantar region of the left hind paw of each rat. Tree hours after carragenean injection, the increase in paw volume was measured with a plethysmometer. The anti-inflammatory activity was measured in terms of percentage inhibition of edema and analyzed (Table V) . Control -no synthesized compound and diclofenac sodium. a Mean ± SEM (n = 6). Significant difference compared with the control: b p < 0.001, c p < 0.01.
Statistical analysis
Statistical analysis of the biological activity of synthesized compounds on animals was evaluated using a one-way analysis of variance (ANOVA). In all cases, posthoc comparisons of the means of individual groups were performed using Tukey's test. All values were expressed as mean ± SEM. The GraphPad Prism 3.0 version was used for statistical analysis. [1, 2, 3] triazoles (3a-h), were obtained by substitution of various aromatic carbonyl and sulphoxide moieties using aromatic acid chlorides in the presence of sodium bicarbonate solution. Formation of the titled compounds was confirmed by the disappearance of the peak due to NH stretching of compound 2. IR spectra of all compounds 3a-h showed the presence of peaks due to (N-N=N) and the tetrazole ring. 1 H NMR spectra of all compounds 3a-h showed absorption signals at d 2.8 and 4.3 ppm for the two methylene protons and multiplet signals between 6.8 and 7.8 ppm for the presence of aromatic protons. Mass spectra of the titled compounds showed molecular ion peaks corresponding to their molecular formula. Elemental analysis satisfactorily confirmed the elemental composition and purity of the synthesized compounds.
The results of analgesic testing indicated that the test compounds 3d and 3g exhibited significant analgesic activity after 15 min of reaction time (13 and 13.83), tested by the hot plate method. Substitution of the amino group in 3d and hydroxyl group in 3g in ortho position of aryl moiety increased the anti-nociceptive activity. All other compounds exhibited moderate anti-nociceptive activity. With the exception of 3b, all the compounds exhibited anti-nociceptive activity tested by the acetic acid induced writhing method at a dose of 18 mg kg -1 . The anti-nociceptive activity of compounds 3d, 3e, 3g and 3h was found to be superior compared to other synthesized compounds. Compounds 3d and 3g were found to be the most active derivatives tested by both the hot plate method and the acetic acid induced writhing method; they possess 2-aminobenzoyl and 2-hydroxybenzoyl group at the tetrazole moiety of the benztriazole framework.
Synthesized compounds 3a-h exhibited poor anti-inflammatory activity (16-22 % protection only) against carragenean induced paw edema, whereas the standard drug diclofenac sodium (Novartis Laboratories, India) showed 61 % inhibition under similar conditions. Among the compounds tested, compounds 3c and 3f exhibited mild anti-inflammatory activity. Inclusion of substituted benzoyl moiety in the tetrazole moiety of benzotriazole framework did not produce any marked inhibition of edema. However, inclusion of substituted sulfonyl moiety in 3f resulted in mild anti-inflammatory properties.
CONCLUSIONS
In the present study, synthesis of a new series of 1-[2-(1H-tetrazol-5-yl)ethyl]-1H--benzo[d] [1, 2, 3] triazoles (3a-h) has been described. Compounds 3d and 3g were found to be the most active derivatives with promising anti-nociceptive activity. We can deduce from the results that replacement of active hydrogen from the tetrazole moiety with substituted benzoyl and sulfonyl moiety can create potent anti-nociceptive compounds, whereas replacement of active hydrogen from the tetrazole moiety with substituted sulfonyl moiety may lead to mild anti-inflammatory activity. Further studies on structural modifications are needed to increase the anti-inflammatory activity.
